ARTA
NSPR icon

A.R.T. Advisors’s InspireMD NSPR Stock Holding History

A.R.T. Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-14
Closed -$10K – 1662
2018
Q1 		$10K Buy
+14
New +$48.2K ﹤0.01% 1454
2017
Q3 		– Sell
-1
Closed -$16K – 1555
2017
Q2 		$16K Hold
1
– – ﹤0.01% 1349
2017
Q1 		$38K Buy
+1
New +$53.4K ﹤0.01% 1345
2016
Q1 		– Hold
0
– -$22K – 1567
2015
Q4 		– Hold
0
– – – 1410

Other funds holding NSPR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

A.R.T. Advisors's NSPR Position: Q2 2018 in Review

A.R.T. Advisors sold out of InspireMD (NSPR) in Q2 2018, closing a stake of 14 shares — an estimated $10K sold.

A.R.T. Advisors first reported a position in NSPR in Q1 2017 and held it in 3 quarters. The position peaked at $38K in Q1 2017. 10 funds tracked by Wall St. Rank hold NSPR as of Q2 2018.

  • A.R.T. Advisors reported no remaining InspireMD position as of Q2 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 14 InspireMD shares in Q2 2018, an estimated $10K.
  • A.R.T. Advisors first reported a position in InspireMD in Q1 2017 and held it in 3 quarters.
  • A.R.T. Advisors's InspireMD position peaked at $38K in Q1 2017.
  • 10 funds tracked by Wall St. Rank held InspireMD as of Q2 2018.

Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.